Drugs / Lumentin® 44
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05781490 | Jan → Feb 2023 | — | Lument AB | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lumentin 44 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05781490 ↗ |
| Route | Oral | “foam for oral use” NCT05781490 ↗ |